Drug
Bacitracin clinical trials
- studies test it
- 10
- open now
- 1
- in phase 3
- 1
- first study started
- 2005
Keep track of what changes. Save the Bacitracin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Brand
Combined with it in one product
Studies by the year they started
10 studies that test it; most in 2009 (2)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2017 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 3
- Phase 3
- 1
- Phase 4
- 2
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 8
Washington University School of Medicine (1) · University of Louisville (1) · Healthpoint (1) · Steward St. Elizabeth's Medical Center of Boston, Inc. (1) · Population Health Research Institute (1) · Mekos Laboratories AS (1) · National Taiwan University Hospital (1) · Susan Hassenbein (1)
Often tested with
Tested in the same studies.
Cefazolin (2) · Gentamicins (1) · Topical Wound Spray HP802-247 (1) · Cephalexin (1) · Polymyxin B (1) · Neomycin (1) · Ascorbic Acid (1) · Bismuth tribromophenate (1)
Studies
Open first, then newest update. How each study uses Bacitracin is read from its arms, and is right about nine times in ten.
Testing it · 10
- Sebum Metabolomics and Lipidomics for Clinical ApplicationsNot yet recruitingNot applicableNational Taiwan University HospitalNCT07549828Written as Bacitracin/Polymyxin B/Neomycin ointment (Yentuogin ointment)
- Bacterial Biofilms in Reconstructive Breast Prostheses Following MastectomyCompletedPhase 1Washington University School of MedicineNCT03213249Written as Bacitracin
- The Relationship of Hemoglobin A1c and Diabetic Wound HealingTerminatedPhase 4Susan HassenbeinNCT01350102Written as Bacitracin
- Polymem vs. Bacitracin/Xeroform in Treating Burn WoundsWithdrawnPhase 1MetroHealth Medical CenterNCT00479193Written as bacitracin/xeroform
- Comparison of Wound Bed Establishment in Facial BurnsCompletedPhase 4University of LouisvilleNCT01668030Written as Bacitracin
- Healing Effects of HP802-247 Versus Antibiotic Ointment in Mohs Micrographic Surgery PatientsCompletedPhase 2HealthpointNCT01359735Written as Bacitracin Ointment
- Effectiveness of Antibiotic Delivery Via Bio-absorbable SpongeCompletedPhase 2Steward St. Elizabeth's Medical Center of Boston, Inc.NCT01222832Written as Bacitracin
- Prevention of Arrhythmia Device Infection Trial (PADIT Pilot)CompletedPhase 3Population Health Research InstituteNCT01002911Written as Cefazolin, Bacitracin, Cefalexin
- Pilot Study To Evaluate A Pharmacologically Active Nasal Sponge Following Endoscopic Sinus SurgeryWithdrawnNot applicableLahey ClinicNCT00705354Written as Bacitracin
- Clinical Evaluation of BacitracinCompletedPhase 2Mekos Laboratories ASNCT00132600Written as bacitracin (allergen)
As the comparator · 2 — what is tested is compared with Bacitracin
- The Use of Medical Grade Honey in the Prevention of Bone Anchored Hearing Aid Associated Skin BreakdownCompletedPhase 4Henry Ford Health SystemNCT03929224Written as Bacitracin
- Use of Amnion on Partial Thickness BurnsWithdrawnPhase 2/3The University of Texas Medical Branch, GalvestonNCT00674999Written as Polysporin/Bacitracin/Mycostatin
Codes
What other systems call Bacitracin · ClinicalTrials.gg INT007042
- MeSH (NLM) D001414BacitracinOne source ClinicalTrials.gov
- UNII (FDA) 58H6RWO52IBACITRACINOne source FDA
- RxNorm 1291One source FDA
- NCI Thesaurus C295BacitracinOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D001414 | Bacitracin | One source ClinicalTrials.gov |
| UNII (FDA) | 58H6RWO52I | BACITRACIN | One source FDA |
| RxNorm | 1291 | — | One source FDA |
| NCI Thesaurus | C295 | Bacitracin | One source FDA |
Also registered as bacitracin zinc (UNII 89Y4M234ES · RxNorm 11417).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.